Madrigal Pharmaceuticals, Inc. (MDGL)

Madrigal Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 12 professional analysts, the 12-month price target for Madrigal Pharmaceuticals stock ranges from a low of $405 to a high of $650. The average analyst price target of $543.33 forecasts a -5.88% decrease in the stock price over the next year.

Price Target: $543.33 (-5.88%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$405	$543.33	$554	$650
Change	-29.85%	-5.88%	-4.04%	+12.59%

Analyst Ratings

The average analyst rating for Madrigal Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	5	5	6	7	8	8
Buy	4	4	2	2	3	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	10	10	9	10	12	13

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $568 → $620	Strong Buy	Maintains	$568 → $620	+7.40%	Nov 21, 2025
Jay Olson Oppenheimer	Oppenheimer	Buy Maintains $600 → $650	Buy	Maintains	$600 → $650	+12.59%	Nov 20, 2025
Srikripa Devarakonda Truist Securities	Truist Securities	Strong Buy Maintains $580 → $640	Strong Buy	Maintains	$580 → $640	+10.86%	Nov 19, 2025
Edward Nash Canaccord Genuity	Canaccord Genuity	Strong Buy Maintains $526 → $587	Strong Buy	Maintains	$526 → $587	+1.68%	Nov 13, 2025
Andrew S. Fein HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $500 → $568	Strong Buy	Maintains	$500 → $568	-1.61%	Nov 11, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

965.59M

Increased by 436.04%

from 180.13M

Revenue Next Year

1.48B

Increased by 53.17%

from 965.59M

EPS This Year

-10.15

from -21.90

EPS Next Year

2.93

from -10.15

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-	-	180.13M	965.59M	1.48B
Revenue Growth	-	-	-	-	-	436.04%	53.17%
EPS	-13.09	-14.63	-17.23	-19.99	-21.90	-10.15	2.93
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	196.70
No. Analysts	-	-	-	-	-	19	18

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	1.0B	1.7B
Avg	965.6M	1.5B
Low	889.8M	1.1B

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	457.9%	72.7%
Avg	436.0%	53.2%
Low	394.0%	16.8%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-8.14	18.42
Avg	-10.15	2.93
Low	-12.51	-7.40

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.